iShares Biotechnology ETF (IBB) Holdings → [Urgent] Protect your money before November (From Weiss Ratings) (Ad) Free IBB Stock Alerts $134.38 -1.06 (-0.78%) (As of 06/18/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends Top 50 IBB HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$467.28-1.4%9.30%1,407,8102AMGNAmgen$305.99+0.9%8.99%2,163,1033REGNRegeneron Pharmaceuticals$1,039.11-0.6%8.34%613,1144GILDGilead Sciences$63.15-1.7%7.13%8,215,2955MRNAModerna$133.27-3.4%5.09%2,418,0256IQVIQVIA$212.93-0.2%3.88%1,294,629 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 7BIIBBiogen$223.65-1.2%3.28%1,039,6548MTDMettler-Toledo International$1,481.07+2.3%2.98%152,4629BNTXBioNTech$86.27-2.5%2.06%1,491,37310ARGXargenx$377.96-0.1%1.90%361,67311ALNYAlnylam Pharmaceuticals$153.86-2.2%1.83%903,59912ILMNIllumina$108.10-0.9%1.78%1,140,61913WATWaters$294.40+0.1%1.74%425,76814GMABGenmab A/S$25.80+0.1%1.57%4,055,14715BMRNBioMarin Pharmaceutical$84.15-1.0%1.47%1,333,95216INCYIncyte$61.44-2.0%1.27%1,599,56617NBIXNeurocrine Biosciences$130.86-3.3%1.26%698,58218BGNEBeiGene$154.70-2.9%1.24%580,40419TECHBio-Techne$74.54-0.4%1.20%1,121,75320NTRANatera$107.99-2.2%1.18%797,39221UTHRUnited Therapeutics$306.04+3.0%1.17%312,53622CRLCharles River Laboratories International$209.72+0.6%1.09%362,22423SRPTSarepta Therapeutics$117.52+0.6%1.02%636,63424MEDPMedpace$402.99+1.8%0.97%177,67525INSMInsmed$65.58+1.4%0.81%1,042,36626RGENRepligen$123.00-1.1%0.76%374,77227PCVXVaxcyte$72.25+0.5%0.73%737,61628LEGNLegend Biotech$40.48-2.5%0.70%1,105,16129ASNDAscendis Pharma A/S$123.19-1.1%0.66%348,50530EXELExelixis$21.56-1.0%0.64%2,127,85131HALOHalozyme Therapeutics$50.27+1.2%0.63%905,40432ITCIIntra-Cellular Therapies$75.48+9.6%0.63%678,64033BPMCBlueprint Medicines$106.71+2.7%0.62%433,25234BRKRBruker$66.79+3.0%0.57%649,33535RVMDRevolution Medicines$37.72+1.7%0.54%981,83836IONSIonis Pharmaceuticals$40.64-0.3%0.52%965,13737CYTKCytokinetics$51.94-1.6%0.51%716,30638ROIVRoivant Sciences$10.84+1.1%0.50%3,473,88439CRSPCRISPR Therapeutics$60.57-2.0%0.47%575,56440APLSApellis Pharmaceuticals$40.07-0.6%0.40%710,587[Urgent] Protect your money before November (Ad)Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis. In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of … Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed.Click here to watch now.41ALKSAlkermes$24.42-2.4%0.39%1,188,45142KRYSKrystal Biotech$173.00-2.7%0.38%169,72643MDGLMadrigal Pharmaceuticals$276.01-0.3%0.38%116,75144BBIOBridgeBio Pharma$27.61+1.4%0.34%933,11045CRNXCrinetics Pharmaceuticals$44.29-0.9%0.32%512,29146RAREUltragenyx Pharmaceutical$37.42-6.0%0.32%555,51347FOLDAmicus Therapeutics$9.77-2.7%0.29%2,063,34148TWSTTwist Bioscience$50.56+3.2%0.29%399,53549ARWRArrowhead Pharmaceuticals$23.58-6.1%0.28%839,57450AXSMAxsome Therapeutics$76.02+0.0%0.28%279,203 Geographic ExposureUnited States96.9%Bermuda0.6%Switzerland0.5%Ireland0.5%Canada0.4%Netherlands0.3%Virgin Islands, British0.3%Jersey0.2%Italy0.1%Cayman Islands0.1%Singapore0.1%Israel0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care87.2%Consumer Discretionary0.4%Energy0.1%Industry ExposureBiotechnology71.0%Health Care Equipment & Supplies9.1%Health Care Providers & Services6.1%Diversified Consumer Services1.0%Distributors0.4%Renewable Energy0.1%Pharmaceuticals0.1%SubIndustry ExposureBiotechnology68.3%Life Sciences Tools & Services9.8%Health Care Services6.1%Pharmaceuticals0.6%Health Care Equipment0.3%Renewable Energy Equipment0.1%Coupon Exposure0-299.8%4-60.2% Related Companies and Tools Related Companies: PPH Holdings BBH Holdings PSCH Holdings PTH Holdings BIB Holdings IBBQ Holdings FTXH Holdings BTEC Holdings MEDX Holdings JDOC Holdings This page (NASDAQ:IBB) was last updated on 6/19/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | SponsoredHistoric NVIDIA partnership could send this tiny AI stock soaring...After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's...Behind the Markets | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThe biggest lie in America unravels…Americans have been fed an insidious lie for decades. Fortunately, it's starting to unravel – and a few powerf...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
